1-20 of 36
Mu Hao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel Indirubin-3-Monoxime Derivative Functions As Regulator of Proteostasis Via Targeting TRIM28 in Multiple Myeloma

Teng Fang, Hao Sun, Xiyue Sun, Zhen Yu, Xiaoyu Zhang, Lanting Liu, Lixin Gong, Shiyi Xie, Mu Hao, Lugui Qiu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6572.
https://doi.org/10.1182/blood-2023-180712
Published: 2023
Journal Articles

CRIP1 Involves the Pathogenesis of Multiple Myeloma Via Dual-Regulation of Proteasome and Autophagy

Zhen Yu, Peixia Tang, Zhenshu Xu, Lugui Qiu, Mu Hao
Journal: Blood
Blood (2023) 142 (Supplement 1): 6598.
https://doi.org/10.1182/blood-2023-179724
Published: 2023
Journal Articles

Enhanced Expression of DNp73 Promotes Drug Resistance and Immune Evasion in Multiple Myeloma By Targeting the MYC and MYCN Pathways

Lanting Liu, Lugui Qiu, Zhen Yu, Mu Hao
Journal: Blood
Blood (2023) 142 (Supplement 1): 4661.
https://doi.org/10.1182/blood-2023-177606
Published: 2023
Journal Articles

High Level of IL-16 Secreted By Non-GCB DLBCL Facilitates Tumor Growth Though the Tumor-Promoting and Immunosuppressive Tumor Microenvironment

Xuwen Guan, Teng Fang, Yi Wang, Wei Liu, Mu Hao, Lugui Qiu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6080.
https://doi.org/10.1182/blood-2023-180840
Published: 2023
Journal Articles

Single-Cell Transcriptome Profiling Reveals Tumor Cell Heterogeneity and Immunosuppressive Microenvironment in Waldenström Macroglobulinemia

Hao Sun, Teng Fang, Tingyu Wang, Zhen Yu, Lixin Gong, Xiaojing Wei, Lugui Qiu, Mu Hao
Journal: Blood
Blood (2022) 140 (Supplement 1): 11872.
https://doi.org/10.1182/blood-2022-164483
Published: 2022
Journal Articles

Immune Profiling of MM Microenvironment at Single-Cell Resolution

Lixin Gong, Hao Sun, Junqiang Lv, Lugui Qiu, Mu Hao
Journal: Blood
Blood (2022) 140 (Supplement 1): 9976–9977.
https://doi.org/10.1182/blood-2022-162341
Published: 2022
Journal Articles

Multiple Myeloma-Derived Mir-27b-3p Facilitates Tumor Progression Via Promoting Tumor Cell Proliferation and Immunosuppressive Microenvironment

Xiaojing Wei, Zhen Yu, Hao Sun, Lixin Gong, Lanting Liu, Teng Fang, Yi He, Tingyu Wang, Weiwei Sui, Yan Xu, Gang An, Xiaoke Ma, Lugui Qiu, Mu Hao
Journal: Blood
Blood (2022) 140 (Supplement 1): 7106–7107.
https://doi.org/10.1182/blood-2022-156759
Published: 2022
Journal Articles

Establishment of Patient-Derived Xenograft (PDX) Zebrafish Model of Multiple Myeloma and Its Application in Drug Screening

Zhen Yu, Ying Li, Kefei Wang, Lu Wang, Lugui Qiu, Mu Hao
Journal: Blood
Blood (2022) 140 (Supplement 1): 12524.
https://doi.org/10.1182/blood-2022-156995
Published: 2022
Journal Articles

Exosome Mirnas Profiling in Serum and Prognostic Evaluation in Patients with Multiple Myeloma

Teng Fang, Hao Sun, Mu Hao, Lugui Qiu
Journal: Blood
Blood (2022) 140 (Supplement 1): 12474–12475.
https://doi.org/10.1182/blood-2022-162902
Published: 2022
Journal Articles

Identifying the Cells of Origin and Risk-Stratification Strategy By Single-Cell Sequencing in Multiple Myeloma

Lixin Gong, Junqiang Lv, Lugui Qiu, Hao Sun, Mu Hao
Journal: Blood
Blood (2022) 140 (Supplement 1): 12473.
https://doi.org/10.1182/blood-2022-159485
Published: 2022
Journal Articles

PHF19 Inhibits Multiple Myeloma Cell Response to Immunotherapy Via Promoting Immunosuppressive Microenvironment

Tengteng Yu, Mu Hao, Hailin Chen, Kenneth Wen, Tingjian Wang, Thomas C.M Smits, Mehmet K. Samur, Eugenio Morelli, Lijie Xing, Liang Lin, Jun Qi, Gang An, Nikhil C Munshi, Yu-Tzu Tai, Lugui Qiu, Kenneth C. Anderson
Journal: Blood
Blood (2022) 140 (Supplement 1): 854–855.
https://doi.org/10.1182/blood-2022-159137
Published: 2022
Journal Articles

Identification of Myeloma-Initiating Cells By Single-Cell RNA Sequencing

Lixin Gong, Hao Sun, Junqiang Lv, Xiaojing Wei, Lanting Liu, Zhen Yu, Yi He, Gang An, Dehui Zou, Lugui Qiu, Mu Hao
Journal: Blood
Blood (2021) 138 (Supplement 1): 2646.
https://doi.org/10.1182/blood-2021-148275
Published: 2021
Journal Articles

The Prognostic Impact of Dynamic Changes of Genetic Risk Stratification in Multiple Myeloma

Huishou Fan, Jiahui Liu, Chenglu Yuan, Xue-Han Mao, MD, Xiaoqing LI, MD, Xin Du, Zengjun Li, Mu Hao, Yuting Yan, Shuhui Deng, MD, Chenxing Du, MD, Chengwen Li, Jiawei Zhao, Shuhua Yi, MD, Dehui Zou, MD, Yaozhong Zhao, Fenghuang Zhan, MD PhD, Yu-Tzu Tai, PhD, Jianxiang Wang, MD, Kenneth Anderson, MD, Lugui Qiu, MD, Gang An, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–3.
https://doi.org/10.1182/blood-2020-139345
Published: 2020
Journal Articles

Genomic and Transcriptomic Profiling Reveals Distinct Subsets Associated with Outcomes in Mantle Cell Lymphoma

Yuting Yan, Shuhua Yi, MD, Meiling Jin, PhD, Yi Wang, Ying Yu, Wang Jun, Dehui Zou, MD, Tingyu Wang, Zhen Yu, MD, Lanting Liu, Rui Cui, MD, Wei Liu, Ryu Lv, Weiwei Sui, MD, Wenyang Huang, Xiong Wenjie, Huijun Wang, Qi Sun, Mu Hao, Jianxiang Wang, MD, Cheng Tao, Lugui Qiu, MD, Lili Wang, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–29.
https://doi.org/10.1182/blood-2020-139955
Published: 2020
Journal Articles

Multiple Myeloma Cell Defects Erythropoiesis and Results Anemia Via High Level of CCL3 in Bone Marrow Microenvironment

Lanting Liu, Zhen Yu, MD, Hui Cheng, Weiwei Sui, Shuhui Deng, MD, Xiaojing Wei, Chenxing Du, MD, Wenyang Huang, Gang An, Wen Zhou, PhD, Tao Cheng, Lugui Qiu, MD, Mu Hao
Journal: Blood
Blood (2020) 136 (Supplement 1): 55.
https://doi.org/10.1182/blood-2020-139006
Published: 2020
Journal Articles

High Level of CCL3 in the Bone Marrow Microenvironment Promotes Anemia By Suppressing the Erythropoiesis Differentiation of Hematopoietic Stem Cells in Myeloma

Lanting Liu, MD, Shuhui Deng, MD, Cheng Tao, Lugui Qiu, MD PhD, Mu Hao
Journal: Blood
Blood (2019) 134 (Supplement_1): 1205.
https://doi.org/10.1182/blood-2019-123891
Published: 2019
Journal Articles

1q21 Gain May Challenge the Role of t(4;14) As an Adverse Prognostic Marker of Multiple Myeloma

Chenxing Du, An Gang, MD, Yan Xu, Xuehan Mao, MD, Yuting Yan, Jiahui Liu, Huishou Fan, Weiwei Sui, Shuhui Deng, MD, Li Zengjun, Chengwen Li, Shuhua Yi, MD, Mu Hao, Dehui Zou, MD, Fenghuang Zhan, MD PhD, Yu-Tzu Tai, PhD, Kenneth C. Anderson, MD, Lugui Qiu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4343.
https://doi.org/10.1182/blood-2019-129739
Published: 2019
Journal Articles

Monitoring the Cytogenetic Architecture of Minimal Residual Plasma Cells Indicates Therapy-Induced Clonal Selection in Multiple Myeloma

Yuting Yan, Yan Xu, Xuehan Mao, MD, Jiahui Liu, Huishou Fan, Qi Wang, Chenxing Du, Li Zengjun, Shuhua Yi, MD, Rui Lv, Shuhui Deng, MD, Weiwei Sui, Mu Hao, PhD, Yu-Tzu Tai, PhD, Nikhil C. Munshi, MD, Gang An, MD, Lugui Qiu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4405.
https://doi.org/10.1182/blood-2019-124096
Published: 2019
Journal Articles

Real-World Outcomes of Ixazomib in the Treatment of Multiple Myeloma from a Single Center in China

Weiwei Sui, Gang An, Shuhui Deng, MD, Yan Xu, Mu Hao, Fu Mingwei, Tingyu Wang, Shuhua Yi, MD, Yaozhong Zhao, Dehui Zou, MD, Zengjun Li, Lugui Qiu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5581.
https://doi.org/10.1182/blood-2019-126718
Published: 2019
Journal Articles

Primary Plasma Cell Leukemia in China: A Retrospective Single Center Study

Tengteng Yu, Yan Xu, MD, An Gang, MD, Zengjun Li, Mu Hao, PhD, Lugui Qiu, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5428.
https://doi.org/10.1182/blood.V130.Suppl_1.5428.5428
Published: 2017